Lisa Larkin | MD, FACP, NCMP, IF

Trained at Yale, and the University of Chicago, Dr. Lisa Larkin is a board-certified internist, business owner, and entrepreneur practicing internal medicine and women’s health in Cincinnati, Ohio, since 1991. She is Founder and CEO of Ms.Medicine, a, national healthcare organization whose mission is to advance healthcare for women through its concierge primary care model and through its education arm, Ms.MedEd, which provides evidence-based information to clinicians and consumers on the complex health needs of women. She is President and Owner of Lisa Larkin, MD, and Associates, an independent, multi-specialty internal medicine and women’s health practice offering Direct Primary Care and concierge primary care. Additionally, she is the Founder and Executive Director of the Cincinnati Sexual Health Consortium, a nonprofit organization formed to improve sexual health and wellness for persons in Cincinnati.

 

She formerly served as Associate Professor and Division Director of Midlife Women’s Health and Primary Care at the University of Cincinnati College of Medicine and as the Director of the UC Health Women’s Center. She is a Fellow of the American College of Physicians, a certified menopause clinician (NCMP), a Fellow of and past member of the Board of Directors of ISSWSH (International Society or the Study of Women’s Sexual Health), and currently serves on the Board of Trustees of NAMS (North American Menopause Society).

 

Dr. Larkin is passionate about raising the standard of care for women and advancing evidence-based women’s healthcare. Considered a national expert in menopause management, sexual medicine and breast cancer risk assessment and prevention, and committed to advancing evidence-based medicine, she is a devoted clinician educator, and lectures frequently at physician CME programs and educational events on women’s health topics.  Dr. Larkin is also well published in the area of menopause and sexual medicine. She participated in the development of and is co-author of several recent important manuscripts, including the ISSWSH consensus guidelines on the identification and evaluation of sexual concerns in women (Mayo Clinic Proceedings 2019), the ISSWSH process of care for the management of hypoactive sexual desire disorder (Mayo Clinic Proceedings 2018), and the NAMS/ISSWSH consensus recommendations for the management of genitourinary syndrome of menopause in women with or at high risk of breast cancer (Menopause 2018). Dr. Larkin also devotes considerable time to women’s health consumer education and is a frequent community lecturer and expert media resource on various women’s health topics. She is also committed to women’s health advocacy. She spoke to the FDA in 2015 as part of a group advocating for the approval of flibanserin, the first FDA-approved medication for female sexual dysfunction, and again in 2016 as part of a group advocating for the label change of local vaginal estrogen. Additionally, she serves as an advisor to several pharmaceutical, consumer product and device companies

 

Named one of Cincinnati’s “Top Docs” every year since 1991 (by Cincinnati Magazine), and winner of the 2019 Health Care Entrepreneur Hero Award by the Cincinnati Business Courier, she is recognized by her peers, patients, members of the community, and the media as an exceptional provider, advocate, educator and innovator and health care disruptor.